Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biokine Therapeutics

Biokine Therapeutics
2ndary - Open LATEST DEAL TYPE (Announced)

Developer of novel drugs designed to identifying novel molecular and cellular mechanisms that regulate tumor development and metastasis. The company's novel drugs offers cancer treatment, mainly leukemia and myeloma, enabling healthcare industries to develop novel therapeutics against these devastating diseases.

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Parent Company
Primary Office
  • Weizmann Science Park
  • PO Box: 2213
  • Rehovot 76120
  • Israel

+972 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Biokine Therapeutics’s full profile, request a free trial.

Biokine Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Open Market 03-Oct-2018 Announced Generating Revenue
5. Merger/Acquisition 00000 Completed Generating Revenue
4. Grant 18-Mar-2009 00.00 00000 Completed Generating Revenue
3. Later Stage VC 10-Jan-2007 00000 00000 Completed Generating Revenue
2. Grant $600K Completed Startup
1. Accelerator/Incubator 01-Jul-2000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Biokine Therapeutics Executive Team (4)

Name Title Board
Amnon Peled Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Orly Eizenberg Ph.D Co-Founder & Vice President, Research & Development

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

Biokine Therapeutics Board Members (6)

Name Representing Role Since Contact
Amnon Peled Ph.D Biokine Therapeutics Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
Anthony Stanton Self Board Member 000 0000
H. Laurence Shaw MD Self Chairman 000 0000
Ofer Goldberg Clal Biotechnology Industries Board Member 000 0000
Shmuel Cabilly Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »